$28.09
1.92% today
Nasdaq, Feb 28, 05:50 pm CET
ISIN
US4158581094
Symbol
HROW
Sector
Industry

Harrow Health, Inc. Stock price

$27.56
-4.73 14.65% 1M
-15.84 36.50% 6M
-5.99 17.85% YTD
+15.86 135.56% 1Y
+19.85 257.46% 3Y
+21.92 388.65% 5Y
+20.06 267.47% 10Y
Nasdaq, Closing price Thu, Feb 27 2025
-0.73 2.58%
ISIN
US4158581094
Symbol
HROW
Sector
Industry

Key metrics

Market capitalization $981.54m
Enterprise Value $1.10b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 363.37
EV/Sales (TTM) EV/Sales 6.53
P/S ratio (TTM) P/S ratio 5.80
P/B ratio (TTM) P/B ratio 17.04
Revenue growth (TTM) Revenue growth 48.15%
Revenue (TTM) Revenue $169.14m
EBIT (operating result TTM) EBIT $-8.57m
Free Cash Flow (TTM) Free Cash Flow $3.04m
Cash position $72.60m
EPS (TTM) EPS $-0.94
P/E forward negative
P/S forward 5.13
EV/Sales forward 5.78
Short interest 11.81%
Show more

Is Harrow Health, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,809 stocks worldwide.

Harrow Health, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

5 Analysts have issued a Harrow Health, Inc. forecast:

5x Buy
100%

Analyst Opinions

5 Analysts have issued a Harrow Health, Inc. forecast:

Buy
100%

Financial data from Harrow Health, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
169 169
48% 48%
100%
- Direct Costs 46 46
35% 35%
27%
123 123
54% 54%
73%
- Selling and Administrative Expenses 108 108
74% 74%
64%
- Research and Development Expense 11 11
169% 169%
6%
4.04 4.04
71% 71%
2%
- Depreciation and Amortization 13 13
24% 24%
7%
EBIT (Operating Income) EBIT -8.57 -8.57
343% 343%
-5%
Net Profit -33 -33
135% 135%
-20%

In millions USD.

Don't miss a Thing! We will send you all news about Harrow Health, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Harrow Health, Inc. Stock News

Positive
Seeking Alpha
11 days ago
Innovation, demand, and shortage of providers have kept healthcare inflation significantly higher than the CPI. Regardless of the political scene, the aging U.S. population and rising chronic illnesses are undeniable truths to face. Income investing ensures consistent returns, allowing flexibility in financial planning, despite volatile stock prices.
Neutral
Business Wire
about one month ago
NASHVILLE, Tenn.--(BUSINESS WIRE)---- $HROW--Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced the launch of its “Harrow Cares” program through a strategic partnership with Cencora (NYSE: COR). Harrow Cares delivers a comprehensive suite of high‑quality access and affordability services, enhancing support for retina specialists, their staff, and pat...
Neutral
Business Wire
about 2 months ago
NASHVILLE, Tenn.--(BUSINESS WIRE)---- $HROW--Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced that Amir H. Shojaei, PharmD, PhD, has joined Harrow as Chief Scientific Officer (CSO). With a remarkable career spanning 28 years in life sciences, Dr. Shojaei brings deep expertise in clinical development, regulatory affairs, and the commercialization of...
More Harrow Health, Inc. News

Company Profile

Harrow Health, Inc. engages in the development, production, and sale of innovative medications. It operates through the Pharmaceutical Compounding and Pharmaceutical Drug Development segments. The Pharmaceutical Compounding segment focuses on the operations of ImprimisRx business. The company was founded by Mark L. Baum and Robert J. Kammer in January 2006 and is headquartered in Nashville, TN.

Head office United States
CEO Mark Baum
Employees 315
Founded 2006
Website www.harrow.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today